Dual-Antiplatelet Therapy Is Not Associated With Greater Odds of Postoperative Bleeding Following Elective Total Joint Arthroplasty
Despite the notable efficacy of DAPT in reducing thromboembolic risk, patients on DAPT did not have higher rates of postoperative bleeding complications within the early postoperative period following elective THA or TKA. These findings suggest that patients on long-term DAPT may safely resume these medications after THA or TKA.
Authors
- Benjamin M. Stronach (ORCID: https://orcid.org/0000-0003-2554-5157)
- Sagar Telang (ORCID: https://orcid.org/0000-0001-5242-9093)
- Arjun Aron (ORCID: https://orcid.org/0009-0000-2823-7075)
- Ryan Palmer (ORCID: https://orcid.org/0000-0001-5201-7371)
- Nathanael D. Heckmann (ORCID: https://orcid.org/0000-0003-1293-1702)
- Jeffrey B. Stambough (ORCID: https://orcid.org/0000-0003-0950-5227)
- Jay R Lieberman
Institutions
- University of Southern California (US)
- Advisory Board Company (United States) (US)
- Heckmann (Germany) (DE)
- University of California Davis Medical Center (US)
Publication Details
- Journal
- Journal of the American Academy of Orthopaedic Surgeons
- Published
- 2025-12-05
- DOI
- https://doi.org/10.5435/jaaos-d-25-00693
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00